Related Experiment Videos
Niacin for stroke prevention: evidence and rationale
Adrienne Keener1, Nerses Sanossian
1Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
CNS Neuroscience & Therapeutics
|December 2, 2008
Summary
Niacin effectively raises high-density lipoprotein (HDL) cholesterol, a key factor in preventing atherothrombotic events like stroke. This review explores niacin
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Low high-density lipoprotein (HDL) cholesterol levels increase atherothrombotic event risk, including stroke.
- Niacin is a proven method for elevating HDL, but its specific role in stroke prevention requires further characterization.
Purpose of the Study:
- To determine the role of niacin in stroke prevention.
- To evaluate niacin's efficacy and safety in stroke patients with low HDL cholesterol.
Main Methods:
- Literature review of PUBMED database using keywords: niacin, stroke, atherosclerosis, carotid artery.
- Analysis of national guidelines from the American Heart Association and National Cholesterol Education Program.
Main Results:
- Niacin effectively raises HDL levels and reduces cardiovascular events in high-risk individuals.
- Niacin can be safely combined with statins, enhancing their efficacy for secondary stroke risk reduction.
- Treatment of stroke patients with low HDL-C using extended-release niacin, alone or with statins, is a viable consideration.
Conclusions:
- Niacin is a potential therapeutic option for stroke patients with low HDL cholesterol.
- Further research is necessary to fully define niacin's role in secondary stroke prevention.
- Combination therapy with niacin and statins shows promise for managing dyslipidemia and reducing stroke risk.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...